{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T06:03:36Z","timestamp":1748325816806},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1991,5,1]],"date-time":"1991-05-01T00:00:00Z","timestamp":673056000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1991,5]]},"DOI":"10.1007\/bf02244563","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T05:03:26Z","timestamp":1132031006000},"page":"106-112","source":"Crossref","is-referenced-by-count":14,"title":["Chronic treatment with chlorpromazine, thioridazine or haloperidol increases striatal enkephalins and their release from rat brain"],"prefix":"10.1007","volume":"104","author":[{"given":"Z. S.","family":"Herman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Huzarska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kmieciak-Ko\u0142ada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02244563_CR1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(70)90006-3","volume":"11","author":"NE Anden","year":"1970","unstructured":"Anden NE, Butcher SG, Corrodi H, Fuxe K, Ungestedt U (1970) Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11:303\u2013314","journal-title":"Eur J Pharmacol"},{"key":"BF02244563_CR2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0143-4179(85)90081-2","volume":"5","author":"D Blanc","year":"1985","unstructured":"Blanc D, Cupo A, Canastas E, Bourhins N, Giraud P, Bannon MJ, Eiden LE (1985) Influence of acute subchronic and chronic treatment with neuroleptic (haloperidol) on enkephalins and their precursors in the striatum of rat brain. Neuropeptides 5:567\u2013570","journal-title":"Neuropeptides"},{"key":"BF02244563_CR3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1126\/science.847477","volume":"196","author":"D Burt","year":"1977","unstructured":"Burt D, Creese I, Snyder S (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196:326\u2013328","journal-title":"Science"},{"key":"BF02244563_CR4","first-page":"81","volume":"217","author":"DB Bylund","year":"1981","unstructured":"Bylund DB (1981) Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors. J Pharmacol Exp Ther 217:81\u201386","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244563_CR5","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/0024-3205(86)90111-6","volume":"39","author":"BH Cohen","year":"1986","unstructured":"Cohen BH, Lipinski JF (1986) In vivo potencies of antipsychotic drugs in blocking alpha1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of actions. Life Sci 39:2571\u20132580","journal-title":"Life Sci"},{"key":"BF02244563_CR6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0014-2999(81)90525-2","volume":"74","author":"J Coupet","year":"1981","unstructured":"Coupet J, Szuchs-Myers VA (1981) Brain histamine H1 and H2 receptors and histamine-sensitive adenylate cyclase: effects of antipsychotics and antidepressants. Eur J Pharmacol 74:149\u2013155","journal-title":"Eur J Pharmacol"},{"key":"BF02244563_CR7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-5728(85)80047-3","volume":"8","author":"A Cupo","year":"1985","unstructured":"Cupo A, Jarry T (1985) Detection of methionine-enkephalin at the 10\u221216 mole levels. J Neuroimmunol 8:57\u201367","journal-title":"J Neuroimmunol"},{"key":"BF02244563_CR8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01253062","volume":"44","author":"R Dunstan","year":"1979","unstructured":"Dunstan R, Jackson DM (1979) Long-term haloperidol treatment of mice: a change in beta-adrenergic receptor responsiveness. J Neurol Transm 44:187\u2013195","journal-title":"J Neurol Transm"},{"key":"BF02244563_CR9","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/0006-2952(83)90397-0","volume":"32","author":"S Flemminger","year":"1983","unstructured":"Flemminger S, Rupniak NMJ, Hall MD, Jenner P, Marsden CD (1983) Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D2 receptors, but not with increases in D1 receptors. Biochem Pharmacol 32:2921\u20132927","journal-title":"Biochem Pharmacol"},{"key":"BF02244563_CR10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0196-9781(87)90014-3","volume":"8","author":"SR George","year":"1987","unstructured":"George SR, Kertesz M (1987) Met-enkephalin concentration in striatum respond reciprocally to alterations in dopamine neurotransmission. Peptides 8:487\u2013492","journal-title":"Peptides"},{"key":"BF02244563_CR11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0024-3205(76)90329-5","volume":"18","author":"G Gianutsos","year":"1976","unstructured":"Gianutsos G, Lal H (1976) Alteration in the action of cholinergic and anticholinergic drugs after chronic haloperidol: indirect evidence for cholinergic hyposensitivity. Life Sci 18:515\u2013520","journal-title":"Life Sci"},{"key":"BF02244563_CR12","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1073\/pnas.77.10.6239","volume":"77","author":"RR Goodman","year":"1980","unstructured":"Goodman RR, Snyder SH, Kuhar MJ, Young WS (1980) Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography. Proc Natl Acad Sci USA 77:6239\u20136243","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02244563_CR13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0143-4179(84)90093-3","volume":"4","author":"ZS Herman","year":"1984","unstructured":"Herman ZS, Kowalski J, Trzeciak HI, Przewiocki R (1984) Enkephalin content in rat striatum during prolonged treatment with fluphenazine. Neuropeptides 4:497\u2013505","journal-title":"Neuropeptides"},{"key":"BF02244563_CR14","first-page":"141","volume":"205","author":"JS Hong","year":"1978","unstructured":"Hong JS, Yang H-YT, Fratta W, Costa E (1978) Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic and antischizophrenic drugs. J Pharmacol Exp Ther 205:141\u2013147","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244563_CR15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0006-8993(79)90618-8","volume":"160","author":"JS Hong","year":"1979","unstructured":"Hong JS, Yang H-YT, Gillin JC, Di Giulio AM, Fratta W, Costa E (1979a) Chronic treatment with haloperidol accelerates the metabolism of enkephalins in rat striatum. Brain Res 160:192\u2013195","journal-title":"Brain Res"},{"key":"BF02244563_CR16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-349-04015-5_9","volume-title":"Endorphins in mental health research","author":"JS Hong","year":"1979","unstructured":"Hong JS, Yang H-YT, Gillin JC, Fratta W, Costa E (1979b) Participation of (Met5)-enkephalin in the action of antipsychotic drugs. In: Usdin E, Bunney WE, Kline NS (eds) Endorphins in mental health research. MacMillan, London, pp 105\u2013114"},{"key":"BF02244563_CR17","first-page":"223","volume-title":"Long-term effects of neuroleptics","author":"JS Hong","year":"1980","unstructured":"Hong JS, Yang H-YT, Gillin, JC, Costa E (1980) Effects of long term administration of antipsychotic drugs on enkephalinergic neurons. In: Cattabeni F, Racagni G, Spano PF, Costa E (eds) Long-term effects of neuroleptics. Raven Press, New York, pp 223\u2013232"},{"key":"BF02244563_CR18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/284515a0","volume":"284","author":"T H\u00f6kfelt","year":"1980","unstructured":"H\u00f6kfelt T, Johansson O, Ljungdabl A, Lundberg JM, Schultzberg M (1980) Peptidergic neurones. Nature 284:515\u2013521","journal-title":"Nature"},{"key":"BF02244563_CR19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000408483","volume":"21","author":"J Hyttel","year":"1983","unstructured":"Hyttel J, Christensen AV, Arnt J (1983) Neuroleptic classification: implications for tardive dyskinesia. Mod Probl Pharmacopsychiatry 21:49\u201364","journal-title":"Mod Probl Pharmacopsychiatry"},{"key":"BF02244563_CR20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1248\/bpb1978.9.88","volume":"9","author":"K Kamata","year":"1986","unstructured":"Kamata K, Ogawa K, Noma S, Kameyama T (1986) Effects of apomorphine on morphine analgesia during the state of dopaminergic supersensitivity after chronic treatment with haloperidol. J Pharmacobiodyn 9:88\u201394","journal-title":"J Pharmacobiodyn"},{"key":"BF02244563_CR21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","volume":"277","author":"JW Kebabian","year":"1979","unstructured":"Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93\u201396","journal-title":"Nature"},{"key":"BF02244563_CR22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0196-9781(80)90056-X","volume":"1","author":"JA King","year":"1980","unstructured":"King JA, Millar RP (1980) Radioimmunoassay of methionine5-enkephalin sulphoxide: phylogenetic and anatomical distribution. Peptides 1:211\u2013216","journal-title":"Peptides"},{"key":"BF02244563_CR23","volume-title":"The rat brain. A stereotaxic of the forebrain and lower parts of the brain stem","author":"JFR K\u00f6nig","year":"1963","unstructured":"K\u00f6nig JFR, Klippel RA (1963) The rat brain. A stereotaxic of the forebrain and lower parts of the brain stem. The Williams and Wilkins Company, Baltimore"},{"key":"BF02244563_CR24","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1126\/science.6139875","volume":"222","author":"DT Krieger","year":"1983","unstructured":"Krieger DT (1983) Brain peptides. What, where and why? Science 222:975\u2013985","journal-title":"Science"},{"key":"BF02244563_CR25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/264567a0","volume":"264","author":"HH Lob","year":"1976","unstructured":"Lob HH, Brase DA, Sampath-Khanna S, Mar JB, Way EL, Li CH (1976) \u03b2-Endorphin in vitro inhibition of striatal dopamine release. Nature 264:567\u2013568","journal-title":"Nature"},{"key":"BF02244563_CR26","first-page":"86","volume":"28","author":"J Mocchetti","year":"1985","unstructured":"Mocchetti J, Schwartz JP, Costa E (1985) Use of mRNA hybridization and radioimmunoassay to study mechanisms of drug-induced accumulation of enkephalin in rat brain structures. Mol Pharmacol 28:86\u201391","journal-title":"Mol Pharmacol"},{"key":"BF02244563_CR27","first-page":"1120","volume":"241","author":"J Mocchetti","year":"1987","unstructured":"Mocchetti J, Naranjo JR, Costa E (1987) Regulation of striatal enkephalin turnover in rats receiving antagonists of specific dopamine receptor subtypes. J Pharmacol Exp Ther 241:1120\u20131124","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244563_CR28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0306-4522(86)90302-7","volume":"19","author":"BJ Morris","year":"1986","unstructured":"Morris BJ, Herz A (1986) Autoradiographical localization in rat brain of \u03ba opiate binding sites labelled by3H-bremazocine. Neuroscience 19:839\u2013846","journal-title":"Neuroscience"},{"key":"BF02244563_CR29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0306-4522(88)90256-4","volume":"25","author":"BJ Morris","year":"1988","unstructured":"Morris BJ, H\u00f6llt V, Herz A (1988a) Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: contrasting effects of D1 and D2 antagonists. Neuroscience 25:525\u2013532","journal-title":"Neuroscience"},{"key":"BF02244563_CR30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0304-3940(88)90484-3","volume":"89","author":"BJ Morris","year":"1988","unstructured":"Morris BJ, H\u00f6llt V, Herz A (1988b) Opioid gene expression in rat striatum is modulated via opioid receptors: evidence from localized receptor inactivation. Neuroscience 89:80\u201384","journal-title":"Neuroscience"},{"key":"BF02244563_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00429171","volume":"60","author":"P Muller","year":"1978","unstructured":"Muller P, Seeman P (1978) Dopaminergic supersensitivity after neuroleptics: time-course and specificity. Psychopharmacology 60:1\u201311","journal-title":"Psychopharmacology"},{"key":"BF02244563_CR32","first-page":"558","volume":"226","author":"JZ Nowak","year":"1983","unstructured":"Nowak JZ, Arbilla S, Galzin AM, Langer SZ (1983) Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol. J Pharmacol Exp Ther 226:558\u2013564","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244563_CR33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00500967","volume":"300","author":"M Nowycky","year":"1976","unstructured":"Nowycky M, Roth R (1976) Presynaptic dopamine receptors: development of supersensitivity following treatment with fluphenazine decanoate. Naunyn-Schmiedebergs Arch Pharmacol 300:247\u2013254","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"BF02244563_CR34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0014-2999(84)90445-X","volume":"99","author":"P Onali","year":"1984","unstructured":"Onali P, Olianas MC, Gessa GL (1984) Selective blockade of dopamine D1 receptors by SCH 23390 discloses striatal dopamine D2 receptors mediating the inhibition of adenylate cyclase in rats. Eur J Pharmacol 99:127\u2013128","journal-title":"Eur J Pharmacol"},{"key":"BF02244563_CR35","first-page":"141","volume-title":"Novel dopamine D2 antagonists for the treatment of schizophrenia","author":"SO \u00d6gren","year":"1988","unstructured":"\u00d6gren SO, H\u00f6gberg T (1988) Novel dopamine D2 antagonists for the treatment of schizophrenia. ISI Atlas of Science: Pharmacology, pp 141\u2013147"},{"key":"BF02244563_CR36","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0306-4522(85)90252-0","volume":"4","author":"G Patey","year":"1985","unstructured":"Patey G, Cupo A, Mazarguil H, Morgat J-L, Rossier J (1985) Release of proenkephalin-derived opioid peptides from rat striatum in vitro and their rapid degradation. Neuroscience 4:1035\u20131044","journal-title":"Neuroscience"},{"key":"BF02244563_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(86)90731-4","volume":"126","author":"F Petit","year":"1986","unstructured":"Petit F, Hamon M, Fournie-Zaluski M-C, Roques BP, Glowi\u0144ski J (1986) Further evidence for a role of \u03b4-opiate receptors in the presynaptic regulation of newly synthesized dopamine release. Eur J Pharmacol 126:1\u20139","journal-title":"Eur J Pharmacol"},{"key":"BF02244563_CR38","first-page":"393","volume":"33","author":"A Plech","year":"1981","unstructured":"Plech A, Stachura Z, Wieloch-Depta L, Herman ZS (1981) Effect of neuroleptics on release acetylcholine to the lateral cerebral ventricle in the rat. Pol J Pharmacol Pharm 33:393\u2013400","journal-title":"Pol J Pharmacol Pharm"},{"key":"BF02244563_CR39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0024-3205(83)90484-8","volume":"33","author":"R Quirion","year":"1983","unstructured":"Quirion R, Zajac JM, Morgat JL, Rocques BP (1983) Autoradiographic distribution of mu and delta opiate receptors in rat brain using highly selective ligands. Life Sci 33:227\u2013230","journal-title":"Life Sci"},{"key":"BF02244563_CR40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0014-2999(84)90478-3","volume":"103","author":"E Richelson","year":"1984","unstructured":"Richelson E, Nelson A (1984) Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. Eur J Pharmacol 103:197\u2013204","journal-title":"Eur J Pharmacol"},{"key":"BF02244563_CR41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/288286a0","volume":"288","author":"BP Roques","year":"1980","unstructured":"Roques BP, Fournie-Zaluski MC, Soroca E, Lecomte JM, Malfroy B, Llorens C, Schwartz J-C (1980) The enkephalinase inhibitor tiorphan shows antinociceptive activity in mice. Nature 288:285\u2013288","journal-title":"Nature"},{"key":"BF02244563_CR42","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0024-3205(76)90321-0","volume":"19","author":"BD Roufogalis","year":"1976","unstructured":"Roufogalis BD, Thornton M, Wade DN (1976) Specifity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists. Life Sci 19:927\u2013934","journal-title":"Life Sci"},{"key":"BF02244563_CR43","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0006-291X(83)91739-4","volume":"113","author":"SL Sabol","year":"1983","unstructured":"Sabol SL, Yoshikawa K, Hong JS (1983) Regulation of met-enkephalin precursor mRNA in rat striatum by haloperidol and lithium. Biochem Biophys Res Commun 113:391\u2013399","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02244563_CR44","first-page":"278","volume":"335","author":"ANM Schoffelmeer","year":"1987","unstructured":"Schoffelmeer ANM, Hogenboom F, Mulder AH (1987) Inhibition of dopamine-sensitive adenylate cyclase by opioids: possible involvement of physically associated \u03bc-and \u03b4-opioid receptors. Naunyn-Schmiedebergs Arch Pharmacol 335:278\u2013284","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"BF02244563_CR45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-2999(88)90094-5","volume":"154","author":"ANM Schoffelmeer","year":"1988","unstructured":"Schoffelmeer ANM, Rice KC, Jacobson AE, Van Geleven JG, Hogenboom F, Heijme MH, Mulder AH (1988) \u03bc-, \u03b4- and \u03ba-opioid receptor \u2014 release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyamate. Eur J Pharmacol 154:169\u2013178","journal-title":"Eur J Pharmacol"},{"key":"BF02244563_CR46","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0028-3908(78)90080-1","volume":"17","author":"JC Schwartz","year":"1978","unstructured":"Schwartz JC, Costentin J, Martres MP, Protais P, Baudry M (1978) Modulation of receptor mechanism in the CNS: hypersensitivity to catecholamines. Neuropharmacology 17:665\u2013685","journal-title":"Neuropharmacology"},{"key":"BF02244563_CR47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.890010203","volume":"1","author":"P Seeman","year":"1987","unstructured":"Seeman P (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1:133\u2013152","journal-title":"Synapse"},{"key":"BF02244563_CR48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ddr.430090108","volume":"9","author":"P Seeman","year":"1986","unstructured":"Seeman P, Grigoriadis D, Niznik HB (1986) Selectivity of agonists and antagonists at D2 dopamine receptors compared to D1 and S2 receptors. Drug Rev Res 9:63\u201369","journal-title":"Drug Rev Res"},{"key":"BF02244563_CR49","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0091-3057(80)90016-7","volume":"13","author":"WH Simmons","year":"1980","unstructured":"Simmons WH, Ritzman RL (1980) An inhibitor of opioid peptide degradation produces analgesia in mice. Pharmacol Biochem Behav 13:715\u2013718","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02244563_CR50","first-page":"186","volume":"30","author":"SP Sivam","year":"1986","unstructured":"Sivam SP, Strunk C, Smith DR, Hong JS (1986) Proenkephalin \u2014 a gene regulation in the rat striatum: influence of lithium and haloperidol. Mol Pharmacol 30:186\u2013191","journal-title":"Mol Pharmacol"},{"key":"BF02244563_CR51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0022-3956(74)90078-8","volume":"11","author":"SH Snyder","year":"1974","unstructured":"Snyder SH, Greenberg D, Yamamura HJ (1974) Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects. J Psychiatr Res 11:91\u201395","journal-title":"J Psychiatr Res"},{"key":"BF02244563_CR52","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1073\/pnas.80.12.3841","volume":"80","author":"F Tang","year":"1983","unstructured":"Tang F, Costa E, Schwartz JP (1983) Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2\u20133 weeks. Proc Natl Acad Sci USA 80:3841\u20133844","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02244563_CR53","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/newbio245262a0","volume":"245","author":"D Tarsy","year":"1973","unstructured":"Tarsy D, Baldessarini RJ (1973) Pharmacologically induced behavioral supersensitivity to apomorphine. Nature New Biol 245:262\u2013263","journal-title":"Nature New Biol"},{"key":"BF02244563_CR54","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0024-3205(75)90176-9","volume":"17","author":"M Trabucchi","year":"1975","unstructured":"Trabucchi M, Longoni R, Fresia P, Spano PF (1975) Sulpiride: a study of the effects on dopamine receptors in rat neostriatum and limbic forebrain. Life Sci 17:1551\u20131556","journal-title":"Life Sci"},{"key":"BF02244563_CR55","first-page":"74","volume-title":"Metabolism of enkephalins","author":"AJ Turner","year":"1987","unstructured":"Turner AJ (1987) Metabolism of enkephalins. ISI Atlas of Science: Pharmacology, pp 74\u201377"},{"key":"BF02244563_CR56","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0163-7258(80)90041-8","volume":"11","author":"DHG Versteeg","year":"1980","unstructured":"Versteeg DHG (1980) Interaction of peptides related to ACTH, MSH and \u03b2-LPH with neurotransmitters in the brain. Pharmacol Ther 11:535\u2013557","journal-title":"Pharmacol Ther"},{"key":"BF02244563_CR57","first-page":"88","volume":"193","author":"PF Voigttlander Von","year":"1975","unstructured":"Von Voigttlander PF, Losey EG, Triezenberg HJ (1975) Increased sensitivity to dopaminergic agent after chronic neuroleptic treatment. J Pharmacol Exp Ther 193:88\u201394","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244563_CR58","first-page":"282","volume":"246","author":"LL Werling","year":"1988","unstructured":"Werling LL, Frattali A, Portoghese PS, Takemori AE, Cox BM (1988) Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. J Pharmacol Exp Ther 246:282\u2013286","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244563_CR59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00501267","volume":"301","author":"D Wesche","year":"1977","unstructured":"Wesche D, H\u00f6llt V, Herz A (1977) Radioimmunoassay for enkephalins. Naunyn-Schmiedebergs Arch Pharmacol 301:79\u201382","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"BF02244563_CR60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0014-2999(83)90105-X","volume":"92","author":"TC Westfall","year":"1983","unstructured":"Westfall TC, Grant H, Naes L, Meldruns M (1983) The effect of opioid drugs on the release of dopamine and 5-hydroxytryptamine from rat striatum following activation of nicotinic-cholinergic receptors. Eur J Pharmacol 92:35\u201342","journal-title":"Eur J Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02244563.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02244563\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02244563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T11:59:23Z","timestamp":1683287963000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02244563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,5]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1991,5]]}},"alternative-id":["BF02244563"],"URL":"https:\/\/doi.org\/10.1007\/bf02244563","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,5]]}}}